AesRx, LLC

AesRx is developing two orphan drugs. Aes-103 for sickle cell disease is a potential blockbuster. Aes-210 for pouchitis is in Phase 2

  • Stage Not Set
  • Industry Biotechnology
  • Location Newton, MA, USA
  • Currency USD
  • Employees 3
  • Website aesrx.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free